Technology transfer / Localization · Africa · Announced 15 Oct 2026
Yangtze River Pharmaceutical → Pharma Invest
Technology transfer / Localization deal between Yangtze River Pharmaceutical (China) and Pharma Invest (Algeria), announced 15 Oct 2026.
Parties: Yangtze River Pharmaceutical Group Co., Ltd. (China) → Pharma Invest SPA (Algeria)
- Deal type
- Technology transfer / Localization
- Value
- Not stated
- Territory
- Africa
- Therapeutic area
- Multi-therapy
- Asset
- Partnership covering (1) technology transfer for producing pharmaceutical raw materials (APIs) and (2) development and manufacture of innovative medicines
- Announced
- 15 Oct 2026
Our analysis
Why this matters
Algeria's 82% formulation self-sufficiency has a structural hole — it still imports most of its active pharmaceutical ingredients. This deal attacks that input layer: state-owned Pharma Invest signed with China's Yangtze River Pharmaceutical Group on 15 October at the Ministry of Pharmaceutical Industry for technology transfer in raw-materials production plus development and manufacture of innovative medicines.
For CEOs: Algiers is moving up the value chain from making medicines to making what medicines are made of.
The full analysis is free to read with a work email on this page.
Source: Algerian Ministry of Pharmaceutical Industry communiqué